Mathematic modeling to predict abruptio placentae

Article Abstract:

Researchers have developed a mathematical model that may predict which pregnant women will develop abruptio placentae. In a review of 170,258 births, 31 risk factors for abruptio placentae were discovered. Abruptio placentae occurs when the placenta detaches from the uterus prematurely.

Abruptio placentae, Placental abruption

---

The effects of intrapartum magnesium sulfate therapy on fetal serum interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha at delivery: a randomized, placebo-controlled trial

Article Abstract:

Giving magnesium sulfate to a pregnant woman in labor does not decrease the level of inflammatory substances in the baby's blood. Elevated levels of these substances have been linked to uterine infection and damage to the baby.

Health aspects, Physiological aspects, Inflammation, Inflammation mediators, Cytokines, Magnesium sulfate

---

Smoking in pregnancy revisited: Findings from a large population-based study

Article Abstract:

The study characterized the effect of smoking on the incidence of various pregnancy complications. It is concluded that smoking decreased the incidence of preeclampsia in a dose-effect manner and is shown to increase the rate of intrauterine growth restriction and preterm delivery.

United States, Causes of, Fetus, Fetal growth retardation, Pregnancy, Complications of, Pregnancy complications, Smoking in pregnancy

Similar abstracts:

• Abstracts: Effects of pregnancy and exercise on concentrations of the metabolic markers tumor necrosis factor alpha and leptin
• Abstracts: Effectiveness of a violence prevention curriculum among children in elementary school: a randomized controlled trial
• Abstracts: Effect of improving depression care on pain and functional outcomes among older adults with arthritis: a randomized controlled trial
• Abstracts: Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial
• Abstracts: The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.